The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessment of safety of bevacizumab (bev) use for metastatic colorectal cancer (mCRC) in elderly patients treated at the Centre Hospitalier de l’Université de Montréal (CHUM): A retrospective study.
Francois-Xavier Bicharh Otte
No relevant relationships to disclose
Francine Aubin
No relevant relationships to disclose
Mustapha Ali Tehfe
No relevant relationships to disclose
Richard Letourneau
No relevant relationships to disclose
Rasmy Lougnarath
No relevant relationships to disclose
Carole S. Richard
No relevant relationships to disclose
Denis Soulieres
No relevant relationships to disclose
Danielle Charpentier
No relevant relationships to disclose
Guy Biron
No relevant relationships to disclose
Jean-Pierre M. Ayoub
No relevant relationships to disclose